1.Insulin therapy for blood glucose fluctuation in diabetes
Chinese Journal of Practical Internal Medicine 2000;0(12):-
For different individuals with diabetes,blood glucose control varies.In the blood glucose controlling,blood glucose levels are sometimes higher than the target,sometimes the diabetic patients may develop hypoglycemia.In insulin therapy for blood glucose fluctuations,the most important thing is to avoid hypoglycemia.Finding out regular patterns of blood glucose fluctuations,then according to that,we need to choose the right insulin preparations to treat the condition.For the patients with irregular fluctuations of blood glucose,insulin pump therapy should be a proper choice.
2.Determination of intrinsic alliin dissolution rates with fiber-optic sensing process analysis.
Jing GENG ; Zicheng ZHANG ; Haibo ZHANG ; Xinxia LI ; Jian CHEN
Acta Pharmaceutica Sinica 2014;49(10):1475-8
The apparatus for intrinsic dissolution test recorded in United States Pharmacopeia (USP) integrating with fiber-optic drug dissolution test system (FODT) were used to real-time monitor intrinsic dissolution processes of alliin in four media which were water, solution of HCl with pH 1.2, buffer solution of acetate with pH 4.5, and buffer solution of phosphate with pH 6.8. The intrinsic dissolution rate (IDR) and the similarity factor (f2) of two intrinsic dissolution curves with two apparatuses were calculated. The IDR values of alliin with rotating disk system were 28.1.3, 33.55, 28.38 and 30.95 mg x cm(-2) x min(-1) in four media, respectively. And the IDR values of alliin with stationary disk system were 44.16, 47.07, 45.11 and 51.34 mg x cm(-2) x min(-1), respectively. The similarity factors were 56.42, 50.75, 40.30 and 40.64, respectively. The results showed that the intrinsic alliin dissolution rates were much greater than 1 mg x cm(-2) x min(-1). It inferred that alliin dissolution would not be the rate limiting step to absorption.
4.Effect of antisense epidermal growth factor receptor cDNA transfection on telomerase activity of glioblastomas cells
Xinxia TIAN ; Yungang ZHANG ; Juan DU ; Jie ZHENG
Journal of Peking University(Health Sciences) 2004;0(03):-
Objective: To study the effects of antisense epidermal growth factor receptor (EGFR) cDNA transfection on telomerase activity and telomere length of glioblastomas U87MG cells and the mechanism. Methods: Glioblastoma U87MG cells, which over-expressed EGFR, were transfected with antisense-EGFR cDNA constructs. Several clones stably expressing lower or undetectable levels of EGFR protein were obtained. The effect of antisense-EGFR cDNA on telomerase activity was assessed by Telomeric Repeat Amplification Protocol (TRAP) assay. The effect of antisense- EGFR cDNA on telomere length was determined by Southern blot hybridization. The mRNA expressions of hTERT, hTEP1 and c-myc were analyzed by semi-quantitative PCR. Results: U87MG cells that were transfected with antisense-EGFR cDNA expressed lower level of EGFR and were less responsive to the growth stimulation of EGF compared with the control cells. Telomerase activity was significantly decreased in the antisense-EGFR clones. Telomere length was shortened. The mRNA expression of hTERT was slightly decreased in the antisense-EGFR clones, whereas the expressions of hTEP1 and c-myc were not altered. Conclusion: Antisense-EGFR cDNA transfection can sufficiently inhibit EGFR signal transduction pathway, decrease telomerase activity and shorten telomere length, which may be a new mechanism of antisense-EGFR approach in tumor suppression. The down-regulation of hTERT mRNA may contribute to the decreased telomerase activity in the antisense-EGFR clones.
5.Intravascular Ultrasonic Features of Unstable Atherosclerotic Plaques in Unstable Angina patients
Song LI ; Hui LIN ; Donghui ZHANG ; Xiaoyang PEI ; Jiheng YANG ; Xuesong HU ; Xinxia ZHANG
Chinese Journal of Primary Medicine and Pharmacy 2010;17(23):3189-3191
Objective To investigate the characteristics of plaque morphology of the patients with unstable angina(UA)by intravascular ultrasound(IVUS). Methods24 patients with stable angina pectoris(SA)and 33 patients with unstable angina(UA)were examined by coronary coronary arteriograph(CAG)and intravascular ultrasound(IVUS).The culprit lesions about the characteristic of the plaque were studied,the external elastic membrane cross-sectional area and lumen cross-sectional area were measured,the plaque area,plaque burden,eccentricity index were calculated,and the remodeling index was examined. ResultsExternal elastic membrane area,plaque area and vascular remodeling ratio were significantly greater at target lesions in UA patients than in patients with SA(P<0.05).Positive remodeling and soft plaque were predominantly in UA patients(P<0.05). ConclusionThe morphological features of coronary artery plaques in UA group were significantly different from those in SA group.More soft plaque,plaque rupture,thrombus formation,and positive remodeling were found in UA patients compared with SA patients.
6.Determination of Five Compounds from Two Species of Chamomiles from Xinjiang by QAMS
Jianguang LI ; Songlin HAN ; Dongsheng ZHAO ; Haibo ZHANG ; Jing GENG ; Xinxia LI
Herald of Medicine 2014;(11):1491-1495
Objective To establish a method of simultaneously quantitative analysis for multi-components by single marker( QAMS)of galuteolin,apigenin-7-glucoside,7-methoxycoumarin,luteolin and apigenin in two species of Chamomiles from Xinjiang. Methods By using apigenin as the internal standard,the relative correction factors( RCF)of galuteolin,apigenin-7-glucoside,7-methoxycoumarin and luteolin were set and determined by UPLC. The contents of galuteolin,apigenin-7-glucoside,7-methoxycoumarin,luteolin and apigenin in 11 samples of Chamomiles were authentically determined by the external standard method,to verify the accuracy of QAMS. Results There is a good linear relationship within the range of standard curve for five compounds by the external standard method(r〉0. 999 3);the average recovery was 99. 7%,97. 5,98. 8%,100. 9%,99. 1%,for galuteolin,apigenin-7-glucoside,7-methoxycoumarin,luteolin and apigenin,respectively,with RSD as 1. 8%,0. 6%,0. 5%, 1. 8% and 1. 9%,respectively. The RCF for pigenin-7-glucoside,galuteolin,7-methoxycoumarin and luteolin to apigenin was 1. 441,2. 308,1. 117,1. 490,respectively,with RSD as 0. 07%,0. 04%,0. 09% and 0. 18%,respectively. No significant difference between the quantitative results by QAMS and external standard method was observed. Conclusion It is practical to determine content of galuteolin,apigenin-7-glucoside,7-methoxycoumarin,luteolin with RCF and apigenin by using external standard method,for the deficiency and expensive of the standard reference.
7.Study of Microelectrode Array Probe for Simultaneous Detection of Glutamate and Local Field Potential during Brain Death
Wenjing WEI ; Yilin SONG ; Xinyi FAN ; Song ZHANG ; Li WANG ; Shengwei XU ; Xinxia CAI
Chinese Journal of Analytical Chemistry 2015;(7):983-988
High extracellular potassium can induce spreading depression-like depolarizations, elevations of extracellular glutamate and even neuronal death in normal brain. To investigate the contribution of high potassium in vivo, a microelectrode arrays ( MEAs ) probe integrated with recording sites for glutamate concentration (50í150 μm) and local field potential ( LFP) ( diameter=15 μm) was fabricated by Micro-electro-mechanical-systems ( MEMS) technologies. We implanted the MEA probe acutely in the rat brain and exposed the brain to a high potassium solution. During these multi-modal recordings, it was observed that high potassium elevated extracellular glutamate while suppressing the LFP irreversibly. This is one of the first studies in which a dual mode MEA probes is applied in vivo for neuronal death, and it is concluded that our MEA probes are capable of examining specific spatiotemporal relationships between electrical and chemical signaling in the brain.
8.The status of liver fibrosis evaluated by non-alcoholic fatty liver disease fibrosis score in hospitalized patients with type 2 diabetes mellitus
Hua BIAN ; Linshan ZHANG ; Hongmei YAN ; Mingfeng XIA ; Xinxia CHANG ; Xin GAO
Chinese Journal of Endocrinology and Metabolism 2014;30(11):960-965
Objective To evaluate the severity of non-alcoholic fatty liver disease(NAFLD) and progressive liver fibrosis(stage>2)in hospitalized patients with type 2 diabetes mellitus(T2DM) by using NAFLD fibrosis score (NFS).The risk factors associated with progressive fibrosis were also analyzed.Methods A total of 721 hospitalized patients with T2DM and uhrasound verified NAFLD were involved.The history information and laboratory examinations were collected,NFS was calculated.The low cutoff score (-1.455) of NFS was used to exclude,and high cutoff score (0.676) to further accurately diagnose progressive fibrosis.Results (1) A total of 721 subjects (male/female 371/350) were diagnosed as NAFLD by ultrasound.In those subjects,173 patients were with progressive fibrosis (24.0%),111 patients without progressive fibrosis (15.4%),and 437 patients (60.6%) with NFS ranged from-1.455 to 0.676.(2) Aging,raised body mass index,aspartate amino transferase/alanine aminotransferase (AST/ALT) ratio,lowered albumin,and platelet were risk factors for progressive fibrosis of NAFLD.In addition,NFS was positively correlated with duration of diabetes,waist circumference,SBP,glycated albumin (GA),and GA/HbA1c(all P<0.01),and negatively with red blood cell count,hemoglobin,white blood cell count (WBC),total cholesterol (TC),triglyceride,apolipoprotein-B,ALT,γ-glutamyltranspeptidase (all P<0.01),AST,low-density lipoprotein cholesterol (all P<0.05).(3) Logistic stepwise regression analysis showed diabetes duration,waist circunference,and GA were positively correlated with progressive liver fibrosis(OR =1.182,1.076,1.074,all P<0.01),and negatively with WBC and TC (OR =0.613,0.703,all P<0.01).Conclusions The detection rate of progressive fibrosis in patients with NAFLD and T2DM was approximately 24.0% by applying NFS.Only 15.4% of those subjects could be excluded from progressive fibrosis.It suggests that we should be alert to the risk of liver fibrosis in patients with type 2 diabetes.
9.Comparison of clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women
Fangfang ZHONG ; Wei ZHANG ; Chenghui WANG ; Xinxia LI ; Ruohong SHUI ; Wentao YANG ; Xiang DU
China Oncology 2014;(1):21-28
Background and purpose: Breast cancer is a group of heterogeneous diseases which has racial disparities. Our study was to elucidate the clinicopathologic features of breast carcinoma in Shanghai Han and Xinjiang Uygur women and to analyze the racial differences. Methods: In this study, 125 cases of breast invasive ductal carcinoma of Shanghai Han women and 85 cases of Xinjiang Uygur women were collected. The clinical stage was analyzed. Histological grading was observed. Immunohistochemical staining of ER, PR, HER-2, CK5/6, CK14, EGFR, Ki-67 was performed. Molecular subtypes were studied. Results:The average age of onset of breast cancer in Xinjiang Uygur women was younger than in Shanghai Han women (P<0.05), and Xinjiang Uygur women were more likely to be diagnosed at less than 35 years old (P<0.01). The proportion of stageⅠwas higher in Shanghai Han women (20.0%vs 8.2%), while the proportion of stageⅢwas higher in Xinjiang Uygur women (50.6%vs 27.2%) (P<0.01). The proportion of grade 2 was higher in Shanghai Han women (67.2% vs 43.5%), while the proportion of grade 3 was higher in Xinjiang Uygur women (47.1%vs 31.2%) (P<0.01). The proportion of luminal A subtype was higher in Shanghai Han women (36.8%vs 18.3%), while the proportion of basal-like subtype was higher in Xinjiang Uygur women (29.6%vs 12.0%) (P<0.01). The molecular subtype was associated with race and histological grade (P<0.05).Conclusion:There are racial differences in clinicopathologic features of breast carcinoma between Shanghai Han and Xinjiang Uygur women.
10.The relationship between liver fat content and liver disease outcome in patients with type 2 diabetes
Linshan ZHANG ; Hua BIAN ; Hongmei YAN ; Mingfeng XIA ; Xinxia CHANG ; Jian GAO ; Xin GAO
Chinese Journal of Endocrinology and Metabolism 2014;30(1):3-7
Objective To investigate the effects of diabetic duration on liver fat content (LFC) in patients with type 2 diabetes,and to explore its relationship with the outcome of liver disease.Methods A total of 435hospitalized patients with type 2 diabetes were recruited.The history data,results of laboratory tests,and hepatic 1 H-MRS were collected,and nonalcoholic fatty liver disease (NAFLD) fibrosis score (NFS) was calculated.Results The prevalence of NAFLD in newly-diagnosed type 2 diabetes mellitus (NT2DM) group was higher than that in predousb-diagnosed type 2 diabetes mellitus (PT2DM) group (92.7% vs 82.2%,P<0.05),with higher LFC [(27.97 ± 16.88 vs 19.44± 15.54) %,P<0.01].The LFC was reduced with prolonged duration of diabetes.Partial correlation analysis showed that LFC was negatively correlated with duration of diabetes (rs =-0.233,P<0.01) after adjustment for gender,age,body mass index (BMI),oral anti-diabetic drugs,lipid-lowering drugs,and insulin treatment.Multiple linear regression analysis showed that LFC was positively correlated with BMI,albumin,and alanine aminotransferase while negatively correlated with duration of diabetes.The proportion of patients without advanced fibrosis (NFS<-1.455) was significantly higher in NT2DM group than that in PT2DM group (26.3% vs 15.5%,P<0.05),and the proportion of PT2DM in patients with advanced fibrosis (NFS>0.676) was significantly higher than that of NT2DM (79.2% vs 20.8%,P<0.05).NFS was positively correlated with the duration of diabetes (rs =0.236,P<0.01).The liver fat content in patients with advanced liver fibrosis decreased significantly,and the LFC was negatively correlated with NFS (rs =-0.164,P<0.01).Conclusions The duration of diabetes is an independent influencing factor of LFC.With the extension of the duration of diabetes,the decreased LFC in type 2diabetic patients with NAFLD is related to the development of advanced fibrosis.The decrease in LFC in type 2diabetic patient is associated with poor outcome of NAFLD.